MORPHOSYS AG's ticker is MOR and the CUSIP is 617760202. A total of 31 filers reported holding MORPHOSYS AG in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,323,617 | +309.3% | 177,191 | +116.4% | 0.05% | +333.3% |
| Q1 2023 | $323,375 | +10.3% | 81,867 | 0.0% | 0.01% | +9.1% |
| Q4 2022 | $293,084 | -28.9% | 81,867 | 0.0% | 0.01% | -35.3% |
| Q3 2022 | $412,000 | +4.0% | 81,867 | 0.0% | 0.02% | +6.2% |
| Q2 2022 | $396,000 | -28.6% | 81,867 | 0.0% | 0.02% | -15.8% |
| Q1 2022 | $555,000 | -28.0% | 81,867 | 0.0% | 0.02% | -24.0% |
| Q4 2021 | $771,000 | -19.9% | 81,867 | 0.0% | 0.02% | -19.4% |
| Q3 2021 | $963,000 | -38.9% | 81,867 | 0.0% | 0.03% | -39.2% |
| Q2 2021 | $1,576,000 | -11.7% | 81,867 | 0.0% | 0.05% | -16.4% |
| Q1 2021 | $1,785,000 | -23.1% | 81,867 | 0.0% | 0.06% | -25.6% |
| Q4 2020 | $2,320,000 | -9.7% | 81,867 | 0.0% | 0.08% | -14.6% |
| Q3 2020 | $2,570,000 | +318.6% | 81,867 | +322.2% | 0.10% | +317.4% |
| Q2 2020 | $614,000 | +29.0% | 19,390 | 0.0% | 0.02% | +4.5% |
| Q1 2020 | $476,000 | -31.2% | 19,390 | 0.0% | 0.02% | -15.4% |
| Q4 2019 | $692,000 | -27.7% | 19,390 | -51.1% | 0.03% | -33.3% |
| Q2 2019 | $957,000 | – | 39,643 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlphaCentric Advisors LLC | 185,000 | $931,000 | 0.96% |
| Ally Bridge Group (NY) LLC | 95,031 | $478,000 | 0.32% |
| Opaleye Management Inc. | 121,015 | $609,000 | 0.25% |
| Endurant Capital Management LP | 68,290 | $344,000 | 0.11% |
| Hudson Bay Capital Management LP | 840,000 | $4,225,000 | 0.04% |
| Tekla Capital Management LLC | 81,867 | $412,000 | 0.02% |
| MILLENNIUM MANAGEMENT LLC | 953,505 | $4,796,000 | 0.00% |
| EVERGREEN CAPITAL MANAGEMENT LLC | 10,248 | $52,000 | 0.00% |
| Candriam S.C.A. | 58,169 | $292,000 | 0.00% |
| QUADRANT CAPITAL GROUP LLC | 876 | $4,000 | 0.00% |